Richard Douglas

Richard Douglas

Net worth: 1 M $ as of 31/05/2026

73 year
Health Technology
Consumer Services

Profile

Richard H.
Douglas
is Independent Chairman at MaxCyte, Inc. since 2021, Chairman at Aldeyra Therapeutics, Inc. since 2016, Independent Director at Novavax, Inc. since 2010, Director at Valneva Usa, Inc. (United States) since 2002, Director at Helio Vision, Inc., and Executive Director at Labyrinth Choir, Inc. Former roles include Director-New Product Development at Integrated Genetics, Inc. from 1982 to 1989 and Senior Vice President-Corporate Development at Genzyme Corp.
from 1989 to 2011.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Michigan.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
20/06/2026 73,220 ( 0.04% ) 803 223 $ 31/05/2026
09/06/2026 1,95,000 ( 0.32% ) 341 250 $ 31/05/2026
17/06/2026 2,60,998 ( 0.24% ) 315 808 $ 31/05/2026

Richard Douglas active positions

CompaniesPositionStart
IOMAI CORPORATION Director/Board Member 01/01/2002
NOVAVAX, INC. Director/Board Member 06/08/2010
ALDEYRA THERAPEUTICS, INC. Chairman -
MAXCYTE, INC. Chairman 03/11/2021
Director/Board Member -
Director/Board Member -

Former positions of Richard Douglas

CompaniesPositionEnd
Corporate Officer/Principal 01/01/2011
Corporate Officer/Principal 01/01/1989
See the detail of Richard Douglas's experience

Training of Richard Douglas

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

89

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

  1. Stock Market
  2. Insiders
  3. Richard Douglas